COVID-19

Outside of the loss of human life due to the COVID-19 pandemic, the past two years have greatly affected hospitals, health systems and the way providers deliver care. Healthcare executives are grappling with federal monetary assistance, growing burnout rates, workforce shortages and federal oversight of vaccines and testing. This channel is also designed to update clinicians on new research and guidelines regarding COVID patient treatment strategies and risk assessments.

PET imaging reveals long-term heart and lung damage from COVID-19
New data highlight the long-lasting effects of the coronavirus, revealing changes that are not detectable by standard medical assessments.
HHS, NIH announce new ‘universal’ vaccine standard for broad-spectrum protection
Currently in development, the “Generation Gold Standard” platform utilizes inert whole viruses to combat more strains of common illnesses, such as COVID and the flu. It’s on track for FDA approval in 2029.
HHS sued over RFK’s $11B cuts to infectious disease control
The Department of Health and Human Services is refusing to allocate funds meant to support state and local healthcare initiatives, as the money stemmed from now-defunct COVID-19 control efforts. A coalition of municipalities is suing to lift the block.
Owner of home healthcare company gets 14 months for defrauding COVID programs
Nakita Cannady, 49, was also convicted of defrauding Cigna to the tune of $194,000, billing the insurer for patient care hours her providers never filled.
Deaths after TAVR are on the rise: Is the pandemic to blame or should cardiologists be concerned?
COVID-19 may help explain the increased rates of cardiac and noncardiac mortality among TAVR patients, but there are several other factors to consider as well. Researchers explored nearly 11 years of STS/ACC registry data to learn more.

High-dose icosapent ethyl treatment makes minimal impact on non-hospitalized COVID-19 patients

The analysis, presented at AHA Scientific Sessions 2021, included approximately 2,000 symptomatic COVID-19 patients who were not necessarily sick enough to be hospitalized.

Taiwan pauses second doses of Pfizer-BioNTech COVID-19 vaccine for older children due to myocarditis

A final decision is expected in approximately two weeks.

FDA recalls 2.2M at-home COVID tests due to false positive results

Ellume was the first company to gain federal authorization for an over-the-counter test to detect COVID-19.

Policy experts call for renewed focus on cardiovascular disease, public health as COVID-19 crisis shows signs of improvement

The world has spent nearly two years now focused on the ongoing COVID-19 pandemic—and with good reason—but are other important healthcare issues now being ignored?

Freestanding imaging centers among those avoiding CMS’ COVID-19 vaccination mandate

The agency also did not include requirements for physician offices or portable X-ray suppliers, while some lawmakers plan to fight the emergency order.

Mild COVID-19 infections not associated with long-term risk of heart damage

The new study, published in JACC: Cardiovascular Imaging, suggests that asymptomatic individuals do not need to be screened after recovering from a mild COVID-19 diagnosis.

CMS finalizes COVID-19 vaccine mandate for healthcare workers, requiring full vaccination by Jan. 4

The policy covers all healthcare providers that participate in Medicare or Medicaid.

coronavirus COVID-19 vaccine vaccination

COVID-19 vaccines are less effective on the immunocompromised

These individuals are less likely to benefit from COVID-19 vaccines, according to a recent study from the Centers for Disease Control and Prevention.

COVID-19

PET imaging reveals long-term heart and lung damage from COVID-19

HHS, NIH announce new ‘universal’ vaccine standard for broad-spectrum protection

HHS sued over RFK’s $11B cuts to infectious disease control

Owner of home healthcare company gets 14 months for defrauding COVID programs

Deaths after TAVR are on the rise: Is the pandemic to blame or should cardiologists be concerned?